๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231

โœ Scribed by Harald Hampel; Katharina Buerger; Russell Kohnken; Stefan J. Teipel; Raymond Zinkowski; Hans-Juergen Moeller; Stanley I. Rapoport; Peter Davies


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
909 KB
Volume
49
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cerebrospinal fluid tau, AรŸ, and phospho
โœ Patrizia Formichi; Carla Battisti; Elena Radi; Antonio Federico ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 285 KB

## Abstract The diagnosis of AD is still largely based on exclusion criteria of secondary causes and other forms of dementia with similar clinical pictures, than the diagnostic accuracy of AD is low. Improved methods of early diagnosis are needed, particularly because drugs treatment is more effect

Large-scale, multicenter study of cerebr
โœ Nobuo Itoh; Hiroyuki Arai; Katsuya Urakami; Koichi Ishiguro; Hideto Ohno; Harald ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 189 KB ๐Ÿ‘ 1 views

We surveyed a total of 570 cerebrospinal fluid (CSF) samples from a variety of diseases, including Alzheimer's disease (AD; n = 236), non-AD-demented and nondemented diseases (n = 239), and normal controls (n = 95) to quantitate levels of tau protein phosphorylated at serine 199 (CSF/phospho-tau199)